FI942046A0 - Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi - Google Patents

Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi

Info

Publication number
FI942046A0
FI942046A0 FI942046A FI942046A FI942046A0 FI 942046 A0 FI942046 A0 FI 942046A0 FI 942046 A FI942046 A FI 942046A FI 942046 A FI942046 A FI 942046A FI 942046 A0 FI942046 A0 FI 942046A0
Authority
FI
Finland
Prior art keywords
preparation
polycyclic compounds
polycyclic
compounds
Prior art date
Application number
FI942046A
Other languages
English (en)
Swedish (sv)
Other versions
FI942046A (fi
Inventor
Oskar Wacker
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI942046A0 publication Critical patent/FI942046A0/fi
Publication of FI942046A publication Critical patent/FI942046A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI942046A 1993-05-07 1994-05-04 Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi FI942046A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140693 1993-05-07
CH33594 1994-02-04

Publications (2)

Publication Number Publication Date
FI942046A0 true FI942046A0 (fi) 1994-05-04
FI942046A FI942046A (fi) 1994-11-08

Family

ID=25684254

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942046A FI942046A (fi) 1993-05-07 1994-05-04 Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi

Country Status (14)

Country Link
US (2) US5382675A (fi)
EP (1) EP0624590A1 (fi)
JP (1) JPH06329678A (fi)
CN (1) CN1097761A (fi)
AU (1) AU680477B2 (fi)
CA (1) CA2122960A1 (fi)
CZ (1) CZ111894A3 (fi)
FI (1) FI942046A (fi)
HU (1) HUT70763A (fi)
IL (1) IL109582A (fi)
MA (1) MA23188A1 (fi)
NO (1) NO941676L (fi)
NZ (1) NZ260459A (fi)
PH (1) PH30300A (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5604219A (en) * 1994-03-18 1997-02-18 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivatives that stimulate platelet production
ES2219670T3 (es) * 1994-11-10 2004-12-01 Millennium Pharmaceuticals, Inc. Utilizacion de compuestos de pirazola para el tratamiento de la glomerulonefritis, cancer, ateroesclerosis o restenosis.
GB9610872D0 (en) * 1996-05-23 1996-07-31 Ciba Geigy Ag Protein kinase assay as a method for identification of fungicides
US6284783B1 (en) 1999-06-09 2001-09-04 The Uab Research Foundation Use of bisindolylmaleimide compounds to induce Fas-mediated apoptosis
US6806266B1 (en) 1999-07-13 2004-10-19 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
JP2007501774A (ja) 2003-08-08 2007-02-01 ノバルティス アクチエンゲゼルシャフト スタウロスポリンを含む組み合わせ
CN111296417B (zh) * 2020-04-01 2021-04-20 广东省农业科学院植物保护研究所 一种星·甲维悬浮剂及其制备方法与应用
CN116041371B (zh) * 2023-01-29 2024-04-19 杭州科兴生物化工有限公司 7-羰基星孢菌素衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100178A (en) * 1976-04-14 1978-07-11 The Upjohn Company 4,5-Didehydro-6-methoxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
US4100177A (en) * 1976-04-14 1978-07-11 The Upjohn Company 4,5-Didehydro-6-hydroxy-2-arylmethoxymethyl-4α-tetrahydropyranacetic acid alkyl esters
US4359424A (en) * 1980-07-07 1982-11-16 Zoecon Corporation Substituted phenoxyethoxytetrahydropyran
US4304924A (en) * 1980-07-07 1981-12-08 Zoecon Corporation Cyclopropylmethyl benzoates
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
WO1991009034A1 (en) * 1989-12-14 1991-06-27 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
US5185260A (en) * 1991-08-29 1993-02-09 The United States Of America As Represented By The United States Department Of Energy Method for distinguishing normal and transformed cells using G1 kinase inhibitors
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
ES2136103T3 (es) * 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.

Also Published As

Publication number Publication date
HUT70763A (en) 1995-10-30
US5382675A (en) 1995-01-17
JPH06329678A (ja) 1994-11-29
NZ260459A (en) 1995-12-21
CN1097761A (zh) 1995-01-25
AU6182894A (en) 1994-11-10
PH30300A (en) 1997-01-20
HU9401347D0 (en) 1994-08-29
NO941676L (no) 1994-11-08
MA23188A1 (fr) 1994-12-31
NO941676D0 (no) 1994-05-06
IL109582A0 (en) 1994-08-26
CA2122960A1 (en) 1994-11-08
AU680477B2 (en) 1997-07-31
FI942046A (fi) 1994-11-08
EP0624590A1 (de) 1994-11-17
IL109582A (en) 1997-09-30
US5455241A (en) 1995-10-03
CZ111894A3 (en) 1994-12-15

Similar Documents

Publication Publication Date Title
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI973426A0 (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
KR950701061A (ko) 방탄제품 및 이의 제조방법(Ballistic-resistane articlt and process for making the same)
IT9047668A1 (it) Composti diossazinici anionici e procedimento per la loro preparazione
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI944713A (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
EE03150B1 (et) Kinoliin-3-karbosamiidühendite kasutamine kasvaja ja septilise šoki vastase kompositsiooni valmistamiseks
FI942958A0 (fi) Materiaaleja ja menetelmiä osteoporoosia estävien aineiden seulomiseksi
FI940775A0 (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
IT1237528B (it) Composti fotocromatici e termocromatici spiro-ossazepin-ossazine e procedimento per la loro preparazione
FI942046A0 (fi) Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
FI955123A (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi
FI944842A (fi) Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
BR9205493A (pt) Composicao farmaceutica e processo para fabricacao de composicao farmaceutica
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos
ZA945878B (en) Process for the preparation of 9-amino camtothecin
NO931839D0 (no) Fremgangsmaate for fremstilling av pergolid
NO961008D0 (no) Fremgangsmåte for fremstilling av cykliske cis-1-amino-2-alkanoler
FI935715A0 (fi) Menetelmä sennosidien A ja B valmistamiseksi
FI943660A0 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
IT9021293A0 (it) Antibiotici ab-023 e processo per la loro preparazione

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed